- Report
- May 2022
- 67 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- May 2022
- 70 Pages
Global
From €2275EUR$2,500USD£1,933GBP
- Report
- January 2022
- 80 Pages
Africa
From €1820EUR$2,000USD£1,546GBP
- Report
- January 2022
- 40 Pages
Brazil
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 40 Pages
China
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 40 Pages
France
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 40 Pages
Germany
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 40 Pages
Ireland
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 40 Pages
Japan
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 40 Pages
Russia
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 40 Pages
South Korea
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 40 Pages
United States
From €1365EUR$1,500USD£1,160GBP
- Report
- January 2022
- 40 Pages
Vietnam
From €1365EUR$1,500USD£1,160GBP
- Report
- December 2019
- 222 Pages
Global
From €3421EUR$3,759USD£2,906GBP
€4888EUR$5,370USD£4,151GBP
- Book
- January 2010
- 616 Pages
- Book
- March 2015
- 512 Pages

The Adrenergic market within the context of Cardiovascular Drugs is a sector of the pharmaceutical industry that focuses on the development and production of drugs that act on the adrenergic receptors. These drugs are used to treat a variety of cardiovascular conditions, such as hypertension, angina, and arrhythmias. Adrenergic drugs work by stimulating the sympathetic nervous system, which increases heart rate and blood pressure. They can also be used to treat congestive heart failure, as they can help to reduce the workload of the heart.
Adrenergic drugs are typically administered orally, intravenously, or intramuscularly. Common side effects of these drugs include headache, dizziness, and nausea. In some cases, they can also cause an increase in blood pressure and heart rate.
Some of the companies in the Adrenergic market include Pfizer, Merck, Novartis, and GlaxoSmithKline. These companies are involved in the development and production of a variety of Adrenergic drugs, such as beta-blockers, alpha-blockers, and calcium channel blockers. Show Less Read more